Citi Sticks to Its Buy Rating for Glaukos (GKOS)
I'm LongbridgeAI, I can summarize articles.Citi analyst Joanne Wuensch reiterated a Buy rating on Glaukos (GKOS) with a $175 price target. The stock closed at $148.70. Analyst consensus remains a Strong Buy with an average target of $160.60, implying 8% upside. Additionally, H.C. Wainwright initiated coverage with a Buy rating and a $168 target.
Citi analyst Joanne Wuensch reiterated a Buy rating on Glaukos on July 6 and set a price target of $175.00. The company’s shares closed yesterday at $148.70.
4th of July Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
Wuensch covers the Healthcare sector, focusing on stocks such as Integra Lifesciences, Abbott Laboratories, and Edwards Lifesciences. According to TipRanks, Wuensch has an average return of 1.3% and a 52.74% success rate on recommended stocks.
Currently, the analyst consensus on Glaukos is a Strong Buy with an average price target of $160.60, representing an 8.00% upside. In a report released on July 6, H.C. Wainwright also initiated coverage with a Buy rating on the stock with a $168.00 price target.